Loading…

Haemonetics (HAE) backlog: remaining performance obligations

How much revenue Haemonetics already has under contract, how fast it converts, and who it is with.

Data as of .

Haemonetics backlog history

$0$500M$1BDec 2022ul 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2026Sep 2026Backlog (RPO)Trailing 12-month revenue
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter endBacklog (RPO)TTM revenueCoverageCustomer prepayments
26 Sep 2026$30.1M$1.38B0.0 yrs$67.3M
27 Jun 2026$31.0M$1.35B0.0 yrs$48.6M
28 Mar 2026$35.9M$1.33B0.0 yrs$42.3M
27 Dec 2025$36.6M$1.32B0.0 yrs$44.6M
27 Sep 2025$35.5M$1.33B0.0 yrs$48.3M
28 Jun 2025$36.0M$1.35B0.0 yrs$49.2M
29 Mar 2025$33.1M$1.36B0.0 yrs$43.3M
28 Dec 2024$33.3M$1.37B0.0 yrs$35.6M
28 Sep 2024$30.5M$1.36B0.0 yrs$36.7M
29 Jun 2024$28.9M$1.33B0.0 yrs$33.6M
30 Mar 2024$26.8M$1.31B0.0 yrs$31.2M
30 Dec 2023$23.5M$1.27B0.0 yrs$31.1M

Questions

What is Haemonetics's backlog?
Haemonetics reported $30.1M of remaining performance obligations at 26 Sep 2026, down 15% from a year earlier and down 3% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 1.00.

About these numbers

Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.